152 related articles for article (PubMed ID: 34758491)
21. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
[TBL] [Abstract][Full Text] [Related]
22. [Analysis of risk factors and construction of predictive nomogram for early recurrence after radiofrequency ablation of hepatocellular carcinoma].
Han RC; Ma XH; Wang S; Yang Y; Feng B; Liang M; Zhao XM
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):546-552. PubMed ID: 34034474
[No Abstract] [Full Text] [Related]
23. Radiofrequency ablation versus surgical resection for intrahepatic hepatocellular carcinoma recurrence: a meta-analysis.
Chen X; Chen Y; Li Q; Ma D; Shen B; Peng C
J Surg Res; 2015 May; 195(1):166-74. PubMed ID: 25724768
[TBL] [Abstract][Full Text] [Related]
24. Pretreatment microbubble-induced enhancement in hepatocellular carcinoma predicts intrahepatic distant recurrence after radiofrequency ablation.
Maruyama H; Takahashi M; Shimada T; Sekimoto T; Kamesaki H; Kanai F; Yokosuka O
AJR Am J Roentgenol; 2013 Mar; 200(3):570-7. PubMed ID: 23436846
[TBL] [Abstract][Full Text] [Related]
25. The role of neoadjuvant conventional transarterial chemoembolization with radiofrequency ablation in the treatment of recurrent hepatocellular carcinoma after initial hepatectomy with microvascular invasion.
Peng Z; Wu X; Li J; Pang H; Zhang Y; Lin M; Wang Z; Xiao H; Li B; Chen M; Feng S; Kuang M; Chen S
Int J Hyperthermia; 2022; 39(1):688-696. PubMed ID: 35469522
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and Safety of Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinomas Compared with Radiofrequency Ablation Alone: A Time-to-Event Meta-Analysis.
Wang X; Hu Y; Ren M; Lu X; Lu G; He S
Korean J Radiol; 2016; 17(1):93-102. PubMed ID: 26798221
[TBL] [Abstract][Full Text] [Related]
27. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
28. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
Tan W; Deng Q; Lin S; Wang Y; Xu G
Int J Hyperthermia; 2019; 36(1):264-272. PubMed ID: 30676100
[TBL] [Abstract][Full Text] [Related]
29. Quantitative Ultrasound Elastography Methods in Focal Liver Lesions Including Hepatocellular Carcinoma: From Diagnosis to Prognosis.
Gu JH; Zhu L; Jiang TA
Ultrasound Q; 2021 Jun; 37(2):90-96. PubMed ID: 34057911
[TBL] [Abstract][Full Text] [Related]
30. Virtual navigation-guided radiofrequency ablation for recurrent hepatocellular carcinoma invisible on ultrasound after hepatic resection.
Zhao QY; Xie LT; Chen SC; Xu X; Jiang TA; Zheng SS
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):532-540. PubMed ID: 33020034
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.
Kawamura Y; Ikeda K; Seko Y; Hosaka T; Kobayashi M; Saitoh S; Kumada H
AJR Am J Roentgenol; 2011 Oct; 197(4):W665-73. PubMed ID: 21940538
[TBL] [Abstract][Full Text] [Related]
32. Radiofrequency ablation versus cryosurgery ablation for hepatocellular carcinoma: a meta-analysis.
Huang YZ; Zhou SC; Zhou H; Tong M
Hepatogastroenterology; 2013; 60(125):1131-5. PubMed ID: 23321123
[TBL] [Abstract][Full Text] [Related]
33. Predisposing factors for recurrence of HBV-related small hepatocellular carcinoma after percutaneous radiofrequency ablation.
Sohn W; Paik YH; Lee MW; Rhim H; Lim HK; Cho JY; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Scand J Gastroenterol; 2014 Mar; 49(3):373-80. PubMed ID: 24354931
[TBL] [Abstract][Full Text] [Related]
34. Iodized oil computed tomography versus ultrasound-guided radiofrequency ablation for early hepatocellular carcinoma.
Wu CH; Liang PC; Su TH; Lin MC; Chang YH; Shih TT; Kao JH
Hepatol Int; 2021 Oct; 15(5):1247-1257. PubMed ID: 34338971
[TBL] [Abstract][Full Text] [Related]
35. Evolution of nodule stiffness might predict response to local ablative therapy: A series of patients with hepatocellular carcinoma.
Praktiknjo M; Krabbe V; Pohlmann A; Sampels M; Jansen C; Meyer C; Strassburg CP; Trebicka J; Gonzalez Carmona MA
PLoS One; 2018; 13(2):e0192897. PubMed ID: 29444164
[TBL] [Abstract][Full Text] [Related]
36. Late recurrence of hepatocellular carcinoma after radiofrequency ablation: a multicenter study of risk factors, patterns, and survival.
Yang Y; Chen Y; Ye F; Cao X; Xin Y; Wang Y; Lei Y; Li X; Feng D; Zhou X; Fan Q
Eur Radiol; 2021 May; 31(5):3053-3064. PubMed ID: 33175203
[TBL] [Abstract][Full Text] [Related]
37. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MR can help determine the treatment method for HCC.
Lee DH; Lee JM; Yu MH; Hur BY; Yi NJ; Lee KW; Suh KS; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
Eur Radiol; 2019 Jun; 29(6):3122-3131. PubMed ID: 30643939
[TBL] [Abstract][Full Text] [Related]
38. Radiofrequency ablation versus hepatic resection for recurrent hepatocellular carcinoma: an updated meta-analysis.
Yang D; Zhuang B; Wang Y; Xie X; Xie X
BMC Gastroenterol; 2020 Nov; 20(1):402. PubMed ID: 33246417
[TBL] [Abstract][Full Text] [Related]
39. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
[TBL] [Abstract][Full Text] [Related]
40. Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis.
Jiang C; Cheng G; Liao M; Huang J
World J Surg Oncol; 2021 Mar; 19(1):81. PubMed ID: 33741001
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
